看好四大赛道，源创多盈“三深”策略深耕产业投资

Core Insights - The company, Yuanchuang Duoying, focuses on technology innovation and has adopted a "three-depth" investment strategy to drive industrial investment and leverage technological value in Shandong province [1][2]. Investment Strategy - The "three-depth" strategy includes "deeply exploring industries," "deeply cultivating regions," and "deeply serving projects," which allows the company to identify and invest in promising projects early [2]. - The company emphasizes early-stage investments, starting from the patent stage of projects, and evaluates the number of published papers and patents in relevant fields [2]. Sector Focus - The company is optimistic about four key sectors: thermal power, electric power, computing power, and life sciences [1]. - In the semiconductor materials sector, Yuanchuang Duoying has invested in approximately 10 next-generation semiconductor material companies, managing over 10 billion yuan in funds and over 130 investment projects [1][4]. Regional Development - The company has established a presence in 15 cities, focusing on cities with either a GDP of over 1 trillion yuan or rich educational resources [4]. - In Jinan, the company has initiated the "Periodic Table Action" to focus on next-generation semiconductor materials, including indium phosphide, gallium arsenide, silicon carbide, and gallium nitride [4]. Life Sciences Sector - The life sciences sector is a major focus, with plans to allocate over 50% of future investments to this area, driven by increasing healthcare spending as GDP per capita exceeds $13,000 [4][5]. - The company aims to invest in synthetic biology, cell and gene therapy, and advanced medical devices, among other promising sub-sectors [5][6]. Market Trends - The domestic life sciences sector has shown significant innovation, transitioning from generic drug production to original innovations, with a notable increase in the number and value of overseas authorizations for innovative drugs [5]. - The market has experienced a complete cycle of bubble formation and burst, leading to more rational valuations and a mature perspective on long-term development in the life sciences sector [6]. Future Outlook - The company is exploring mergers and acquisitions and aims to support traditional enterprises through industrial integration [7]. - Yuanchuang Duoying plans to maintain its commitment to technology investment and aims to achieve a managed scale of 10 billion yuan by 2029 [7].